Peter P. Lee

City Of Hope National Medical Center — United States

Medicine · Health Sciences

63h-index15.1kcitations423works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(163), Immunotherapy and Immune Responses(127), Immune Cell Function and Interaction(63), T-cell and B-cell Immunology(58), CAR-T cell therapy research(35)

Publications423 total

Author Correction: Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
npj Breast Cancer·2026Open Access
The Need for Clinical Trial Dataset Specifications to Support Clinical Pharmacology Review of Immunogenicity
The AAPS Journal·2026
Baseline tumor features and systemic immune dynamics underlying efficacy in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumab
Cancer Immunology Research·2026
Abstract PS1-10-19: Palbociclib, pembrolizumab, and endocrine therapy in HR+/HER2- metastatic breast cancer: Updated results from a phase I/II trial
Clinical Cancer Research·2026
Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework
Bulletin of Mathematical Biology·2026Open Access
Ligand discrimination in immune cells: Signal processing insights into immune dysfunction in ER+ breast cancer
PLoS Computational Biology·2025Open Access
Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework
2025Open Access
Optimisation of neoadjuvant pembrolizumab therapy for locally advanced MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations
Journal of Theoretical Biology·2025· 4 citedOpen Access
Pressing extraction: A novel and environmentally sustainable approach to microbial lipid extraction from Yarrowia lipolytica
Separation and Purification Technology·2025· 2 citedOpen Access
Long-term clinical outcomes with nivolumab/ipilimumab with or without <i>Clostridium butyricum</i> MIYAIRI588 in metastatic renal cell carcinoma (mRCC): A randomized phase Ib clinical trial.
Journal of Clinical Oncology·2025· 1 cited
A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer.
Journal of Clinical Oncology·2025· 3 cited
Sensitivity analysis-guided model reduction of a mathematical model of pembrolizumab therapy for de novo metastatic MSI-H/dMMR colorectal cancer
arXiv (Cornell University)·2025Open Access
Optimisation of pembrolizumab therapy for de novo metastatic MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations
2025· 1 citedOpen Access
Engineering Yarrowia lipolytica for enhanced lipid productivity in nutrient-rich conditions: A scalable approach to microbial lipid production
Metabolic Engineering·2025· 5 citedOpen Access
Lymphocytes and monocytes undergo swift suppression of IL-10R, IL-6R, and IL-2Rβγ signaling under high concentrations of different cytokines
2025Open Access
Nasal Epithelial Gene Expression Analyses of Candidate Senescence Genes Identify MMP2 and FN1 Associated With Asthma Susceptibility and Severity in the ATLANTIS Study
American Journal of Respiratory and Critical Care Medicine·2025
Abstract 7164: Predictive biomarkers and immune dynamics in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumab
Cancer Research·2025
Abstract 5133: End-stage breast cancer metastases manifest as two subtypes with distinct dissemination patterns, proliferation/EMT signatures, and immune microenvironments
Cancer Research·2025· 1 cited
Ligand Discrimination in Immune Cells: Signal Processing Insights into Immune Dysfunction in ER+ Breast Cancer
2025Open Access
Dose finding study of CBM588 in combination with nivolumab and ipilimumab in patients with metastatic renal cell carcinoma: A phase I study.
Journal of Clinical Oncology·2025
page 1 of 22Next →

Frequent Co-authors

Jeffrey S. Weber(10), Mark M. Davis(8), Tor B. Stuge(7), Diana L. Simons(5), Susan Holmes(5), Denise Johnson(4), Peter J. Rosen(4), Travis Y. Tu(4), John H. Yim(4), Cassian Yee(3), Philip D. Greenberg(3), Mario Roederer(3), Jeffrey J. Molldrem(3), Susan Groshen(3), Valerie Rubio(3), Colt A. Egelston(3), Stephen J. Forman(3), Laura Kruper(3), Joanne Mortimer(3), Rebecca J. Critchley-Thorne(3)